Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-21 Sale |
2025-03-25 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
9,766 | $293.36 | $2,864,985 | 20,902 (Indirect Direct) |
View |
| 2025-03-24 Sale |
2025-03-25 4:09 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,440 | $299 | $2,224,560 | 28,036 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,755 | $242.94 | $669,304 | 21,857 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
471 | $243.78 | $114,820 | 35,830 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
2,557 | $242.92 | $621,150 | 33,042 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,264 | $243.78 | $308,141 | 57,608 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:20 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
3,877 | $243.79 | $945,165 | 135,335 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:32 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
2,900 | $241.69 | $700,894 | 90,875 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
796 | $241.7 | $192,390 | 35,863 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
513 | $241.68 | $123,983 | 16,011 (Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
935 | $241.69 | $225,977 | 15,551 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:30 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
496 | $241.69 | $119,878 | 12,922 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:49 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
1,213 | $255.17 | $309,527 | 81,933 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
967 | $255.17 | $246,750 | 32,843 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,103 | $252.71 | $531,448 | 13,418 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,109 | $253.43 | $787,904 | 12,670 (Indirect Direct) |
View |
| 2025-01-27 Sale |
2025-01-29 4:03 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
52,592 | $285 | $14,988,720 | 12,670 (Indirect Direct) |
View |
| 2025-01-23 Sale |
2025-01-24 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
11,250 | $275 | $3,093,750 | 266,899 (Indirect Direct) |
View |
| 2024-12-12 Sale |
2024-12-13 4:13 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,752 | $251 | $439,760 | 16,386 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
5,219 | $250.98 | $1,309,853 | 79,287 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,682 | $250.98 | $422,144 | 18,138 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,682 | $250.98 | $422,144 | 30,701 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,469 | $250.98 | $368,686 | 13,191 (Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:20 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
3,000 | $251.65 | $754,947 | 13,418 (Indirect Direct) |
View |
| 2024-08-20 Sale |
2024-08-22 8:01 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,000 | $280 | $4,200,000 | 76,200 (Indirect Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:12 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
22,025 | $270.99 | $5,968,516 | 15,610 (Indirect Direct) |
View |
| 2024-08-06 Sale |
2024-08-08 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
20,250 | $262 | $5,305,586 | 3,636 (Indirect Direct) |
View |
| 2024-08-01 Sale |
2024-08-02 8:01 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,148 | $270 | $4,089,960 | 91,200 (Indirect Direct) |
View |
| 2024-07-11 Sale |
2024-07-12 8:02 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
7,093 | $261 | $1,851,273 | 73,848 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 4:04 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $240 | $2,040,000 | 11,186 (Direct) |
View |
| 2024-06-24 Sale |
2024-06-26 4:28 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
32,450 | $220.69 | $7,161,360 | 43,086 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-26 4:28 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
2,103 | $230.99 | $485,773 | 16,290 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-26 4:27 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
8,301 | $230.99 | $1,917,475 | 80,941 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,605 | $231 | $370,747 | 28,949 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,605 | $231 | $370,747 | 11,660 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-24 Exercise |
2025-03-25 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
5,445 | $42.22 | 20,902 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-25 4:10 pm |
N/A 2026-12-20 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
5,445 | $0 | 20,902 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-25 4:09 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,440 | $88.95 | 28,036 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-25 4:09 pm |
N/A 2025-12-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,440 | $0 | 28,036 (Direct) |
View |
| 2025-03-13 Exercise |
2025-03-14 4:16 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
2,750 | $131.21 | 11,186 (Direct) |
View |
| 2025-03-13 Exercise |
2025-03-14 4:16 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
2,750 | $0 | 11,186 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:23 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary |
2,286 | $0 | 9,531 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:22 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
11,690 | $0 | 21,857 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:22 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
21,956 | $0 | 35,830 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:21 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
21,956 | $0 | 33,042 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:21 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
24,917 | $0 | 57,608 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:20 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
54,258 | $0 | 135,335 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:32 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
5,921 | $0 | 90,875 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,908 | $0 | 35,863 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,667 | $0 | 16,011 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,908 | $0 | 15,551 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:49 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
3,859 | $0 | 81,933 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,109 | $0 | 32,843 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,103 | $0 | 13,418 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,109 | $0 | 12,670 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 4:03 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
48,876 | $88.95 | 12,670 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 4:03 pm |
2019-08-06 2025-12-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
48,876 | $0 | 12,670 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-24 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
11,250 | $131.21 | 266,899 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-24 4:10 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
11,250 | $0 | 266,899 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:22 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
10,658 | $0 | 79,287 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:22 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,434 | $0 | 18,138 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:21 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,434 | $0 | 30,701 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:21 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
3,000 | $0 | 13,191 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:20 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
3,000 | $0 | 13,418 (Direct) |
View |
| 2024-10-08 Option Award |
2024-10-10 4:06 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
96 | $0 | 16,386 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 4:11 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary |
7,245 | $0 | 7,245 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-22 8:01 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,000 | $85 | 76,200 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-22 8:01 pm |
N/A 2029-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,000 | $0 | 76,200 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
6,667 | $97.72 | 15,610 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
14,058 | $85 | 15,610 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A 2029-02-28 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
20,725 | $0 | 15,610 (Direct) |
View |
| 2024-08-06 Exercise |
2024-08-08 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
9,000 | $105.26 | 3,636 (Direct) |
View |
| 2024-08-06 Exercise |
2024-08-08 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
11,250 | $131.21 | 3,636 (Direct) |
View |
| 2024-08-06 Exercise |
2024-08-08 4:10 pm |
2019-06-20 2028-06-19 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
20,250 | $0 | 3,636 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-02 8:01 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,148 | $85 | 91,200 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-02 8:01 pm |
N/A 2029-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,148 | $0 | 91,200 (Direct) |
View |
| 2024-06-25 Exercise |
2024-06-27 4:04 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $131.21 | 11,186 (Direct) |
View |
| 2024-06-25 Exercise |
2024-06-27 4:04 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $0 | 11,186 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
17,560 | $88.95 | 43,086 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,470 | $71.99 | 43,086 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,420 | $70.2 | 43,086 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-26 4:28 pm |
2017-06-03 2026-06-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
32,450 | $0 | 43,086 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,295 | $0 | 16,290 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 4:27 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
16,953 | $0 | 80,941 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,278 | $0 | 28,949 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
3,278 | $0 | 11,660 (Direct) |
View |